pubmed-article:21167961 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:21167961 | lifeskim:mentions | umls-concept:C0006104 | lld:lifeskim |
pubmed-article:21167961 | lifeskim:mentions | umls-concept:C0205147 | lld:lifeskim |
pubmed-article:21167961 | lifeskim:mentions | umls-concept:C0026237 | lld:lifeskim |
pubmed-article:21167961 | lifeskim:mentions | umls-concept:C0010592 | lld:lifeskim |
pubmed-article:21167961 | lifeskim:mentions | umls-concept:C0021081 | lld:lifeskim |
pubmed-article:21167961 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:21167961 | lifeskim:mentions | umls-concept:C0243072 | lld:lifeskim |
pubmed-article:21167961 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:21167961 | pubmed:dateCreated | 2011-4-12 | lld:pubmed |
pubmed-article:21167961 | pubmed:abstractText | We studied the functional properties of isolated brain mitochondria (BM) prepared from total rat brain (BM(total)) or from cerebral subregions under basal and Ca(2+) overload conditions in order to evaluate the effects of cyclosporine A (CsA) in a regiospecific manner. CsA-induced effects were compared with those of two derivatives-the none-immunosuppressive [O-(NH(2)(CH2)(5)NHC(O)CH(2))-D-Ser](8)-CsA (Cs9) and its congener, the immunosuppressive [D-Ser](8)-CsA. The glutamate/malate-dependent state 3 respiration of mitochondria (state 3(glu/mal)) differed in region-specific manner (cortex > striatum = cerebellum > substantia nigra > hippocampus), but was significantly increased by 1?M CsA (+21±5%) in all regions. Ca(2+) overload induced by addition of 20?M Ca(2+) caused a significant decrease of state 3(glu/mal) (-45 to -55%) which was almost completely prevented in the presence of 1?M CsA, 1?M Cs9 or 1?M [D-Ser](8)-CsA. Mitochondrial Ca(2+) accumulation thresholds linked to permeability transition (PT) as well as the rate and completeness of mitochondrial Ca(2+) accumulation differed between different brain regions. For the first time, we provide a detailed, regiospecific analysis of Ca(2+)-dependent properties of brain mitochondria. Regardless of their immunosuppressive impact, CsA and its analogues improved mitochondrial functional properties under control conditions. They also preserved brain mitochondria against Ca(2+) overload-mediated PT and functional impairments. Since Cs9 does not mediate immunosuppression, it might be used as a more specific PT inhibitor than CsA. | lld:pubmed |
pubmed-article:21167961 | pubmed:language | eng | lld:pubmed |
pubmed-article:21167961 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21167961 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:21167961 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21167961 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21167961 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21167961 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:21167961 | pubmed:month | May | lld:pubmed |
pubmed-article:21167961 | pubmed:issn | 1872-8278 | lld:pubmed |
pubmed-article:21167961 | pubmed:author | pubmed-author:HeinzeHans-Jo... | lld:pubmed |
pubmed-article:21167961 | pubmed:author | pubmed-author:FischerGunter... | lld:pubmed |
pubmed-article:21167961 | pubmed:author | pubmed-author:VielhaberStef... | lld:pubmed |
pubmed-article:21167961 | pubmed:author | pubmed-author:GellerichFran... | lld:pubmed |
pubmed-article:21167961 | pubmed:author | pubmed-author:GizatullinaZe... | lld:pubmed |
pubmed-article:21167961 | pubmed:author | pubmed-author:MalesevicMiro... | lld:pubmed |
pubmed-article:21167961 | pubmed:author | pubmed-author:StriggowFrank... | lld:pubmed |
pubmed-article:21167961 | pubmed:author | pubmed-author:SvobodaHannoH | lld:pubmed |
pubmed-article:21167961 | pubmed:author | pubmed-author:JerzembekDore... | lld:pubmed |
pubmed-article:21167961 | pubmed:author | pubmed-author:GaynutdinovTi... | lld:pubmed |
pubmed-article:21167961 | pubmed:author | pubmed-author:KnabeAnnetteA | lld:pubmed |
pubmed-article:21167961 | pubmed:copyrightInfo | Copyright © 2010 Elsevier B.V. and Mitochondria Research Society. All rights reserved. | lld:pubmed |
pubmed-article:21167961 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:21167961 | pubmed:volume | 11 | lld:pubmed |
pubmed-article:21167961 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:21167961 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:21167961 | pubmed:pagination | 421-9 | lld:pubmed |
pubmed-article:21167961 | pubmed:meshHeading | pubmed-meshheading:21167961... | lld:pubmed |
pubmed-article:21167961 | pubmed:meshHeading | pubmed-meshheading:21167961... | lld:pubmed |
pubmed-article:21167961 | pubmed:meshHeading | pubmed-meshheading:21167961... | lld:pubmed |
pubmed-article:21167961 | pubmed:meshHeading | pubmed-meshheading:21167961... | lld:pubmed |
pubmed-article:21167961 | pubmed:meshHeading | pubmed-meshheading:21167961... | lld:pubmed |
pubmed-article:21167961 | pubmed:meshHeading | pubmed-meshheading:21167961... | lld:pubmed |
pubmed-article:21167961 | pubmed:meshHeading | pubmed-meshheading:21167961... | lld:pubmed |
pubmed-article:21167961 | pubmed:meshHeading | pubmed-meshheading:21167961... | lld:pubmed |
pubmed-article:21167961 | pubmed:meshHeading | pubmed-meshheading:21167961... | lld:pubmed |
pubmed-article:21167961 | pubmed:meshHeading | pubmed-meshheading:21167961... | lld:pubmed |
pubmed-article:21167961 | pubmed:year | 2011 | lld:pubmed |
pubmed-article:21167961 | pubmed:articleTitle | Effects of cyclosporine A and its immunosuppressive or non-immunosuppressive derivatives [D-Ser]8-CsA and Cs9 on mitochondria from different brain regions. | lld:pubmed |
pubmed-article:21167961 | pubmed:affiliation | Leibniz Institute for Neurobiology, Department Behavioral Neurology, Brenneckestr. 6, D-39118 Magdeburg, Germany. | lld:pubmed |
pubmed-article:21167961 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:21167961 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |